# pathway_0183: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0183.txt)

**Task:** `pathway`  
**Author key, unchanged:** **C** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MYDVIVIGAGWCGLVAAKTYLQACPDAQVLIVDGDTSIGGTWSKERLYPHLVAEAHYGLFEFSDLPMNGDSVLPDGRIPSTAVHAYLVEYATKFNLIQRIRLNTWIENVRREAGELGMHWTLTAAGSQEQLHAKKVIITTGLTSEAFIPSLPGRDEFEGEVLHSKALGHPQTVERISDPSIRHVVVYGGSKSAFDAVYLLLRAGKTVDWVIREGGGGPSMMTPLSVLGQPSFRLNNSRLLALLSPHPFGTPGEQLSWWQRVVHHRSGQWAQFMILTIWRVMNYLFLRPWGYDSSPNGKRLKPLLGLDSLFWSPATLGVMTHPELWEEIHSGQRVKIHRDAITGLARDKRVMLSSGQELSSADLVVCATGWHARHSFFAPEEQLAVGLPGTASFDPKSQQKWLDLQRTADREITEELPILQKNPIPPPPLRCEDDHHLYRFIAPSRETPSHERSIAFVGFLRTAGAPIVYEAQSLWATAYLTGALEVPEAPQREREIARTNAWIRRRYLCGRKVPFALFDFLPYVDMLYRDLGINPNRKPNQIAELCGLYRPQDFKGVVSEWLANQQAKDVNGN

[Multiple Choices]
A. ajmaline biosynthesis. .
B. Protein modification
C. Antifungal biosynthesis. .
D. chorismate from D-erythrose 4-phosphate and phosphoenolpyruvate: step 7/7. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence exactly matches the UniProt record, which annotates the protein to antifungal biosynthesis and cites a publication with functional and pathway evidence. This supports the key as an annotation-backed claim; the cited primary study was not independently reviewed here.

Citations as saved: [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence may suggest an enzyme, but general sequence features do not identify which specific biosynthetic pathway it serves.


**Missing item-specific fact**

> The protein-specific functional assignment linking this sequence to the restricticin/antifungal biosynthesis pathway, or equivalent pathway evidence.


**Reason**

> Distinguishing antifungal biosynthesis from the other named pathways requires protein-specific annotation or experimental context absent from the prompt. Recognizing the sequence or recalling its database record would be lookup or memorization, not reasoning from the supplied input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The choices name distinct pathway categories, and the supporting annotation selects C. The lack of sequence-based grounds to identify that pathway is a lookup-dependence issue, not evidence that multiple choices are equally correct.


### Important caveats

- The pathway claim is supported by a UniProt annotation carrying ECO:0000269 and a publication citation; the primary paper's results were not independently checked.
- The sequence match and relevant historical record support applying the annotation to this sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence may suggest an enzyme, but general sequence features do not identify which specific biosynthetic pathway it serves.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional assignment linking this sequence to the restricticin/antifungal biosynthesis pathway, or equivalent pathway evidence.",
    "reason": "Distinguishing antifungal biosynthesis from the other named pathways requires protein-specific annotation or experimental context absent from the prompt. Recognizing the sequence or recalling its database record would be lookup or memorization, not reasoning from the supplied input."
  },
  "case_id": "pathway_0183",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt record, which annotates the protein to antifungal biosynthesis and cites a publication with functional and pathway evidence. This supports the key as an annotation-backed claim; the cited primary study was not independently reviewed here."
  },
  "important_caveats": [
    "The pathway claim is supported by a UniProt annotation carrying ECO:0000269 and a publication citation; the primary paper's results were not independently checked.",
    "The sequence match and relevant historical record support applying the annotation to this sequence, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices name distinct pathway categories, and the supporting annotation selects C. The lack of sequence-based grounds to identify that pathway is a lookup-dependence issue, not evidence that multiple choices are equally correct."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0183",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt record, which annotates the protein to antifungal biosynthesis and cites a publication with functional and pathway evidence. This supports the key as an annotation-backed claim; the cited primary study was not independently reviewed here.",
    "evidence_ids": ["H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence may suggest an enzyme, but general sequence features do not identify which specific biosynthetic pathway it serves.",
    "missing_item_specific_fact": "The protein-specific functional assignment linking this sequence to the restricticin/antifungal biosynthesis pathway, or equivalent pathway evidence.",
    "reason": "Distinguishing antifungal biosynthesis from the other named pathways requires protein-specific annotation or experimental context absent from the prompt. Recognizing the sequence or recalling its database record would be lookup or memorization, not reasoning from the supplied input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices name distinct pathway categories, and the supporting annotation selects C. The lack of sequence-based grounds to identify that pathway is a lookup-dependence issue, not evidence that multiple choices are equally correct."
  },
  "important_caveats": [
    "The pathway claim is supported by a UniProt annotation carrying ECO:0000269 and a publication citation; the primary paper's results were not independently checked.",
    "The sequence match and relevant historical record support applying the annotation to this sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches UniProt entry P0DXV5 (RESA_ASPSL, FAD-dependent monooxygenase resA / Restricticin biosynthesis cluster protein A) from Aspergillus sclerotiorum. The pathway comment explicitly states 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay), referencing PubMed:39105744 (2024, J. Agric. Food Chem.). The protein is part of the restricticin biosynthesis cluster, and restricticin is an antifungal compound. The annotation is experimentally supported.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains a Rossmann-fold-like FAD-binding motif (GAGWCGLVAA near N-terminus), consistent with FAD-dependent monooxygenase activity. This could help eliminate option D (chorismate step 7/7 = DAHP synthase, a completely different enzyme class) and arguably option A (ajmaline biosynthesis is a plant-specific alkaloid pathway involving strictosidine synthase and other enzymes, not FAD monooxygenases). However, FAD-dependent monooxygenases participate in numerous fungal secondary metabolite pathways, and the specific assignment to 'Antifungal biosynthesis' (i.e., the restricticin cluster) cannot be derived from sequence motifs alone.


**Missing item-specific fact**

> The specific identity of this protein as 'Restricticin biosynthesis cluster protein A' and the classification of the restricticin pathway under 'Antifungal biosynthesis' in UniProt. This is a very recent annotation (entry first published 2025-02-05, reference paper 2024) and the restricticin biosynthesis cluster was characterized via genome mining and heterologous expression. Without knowing the protein's specific role in the restricticin gene cluster, a model cannot uniquely assign it to 'Antifungal biosynthesis' rather than another fungal secondary metabolite biosynthesis pathway.


**Reason**

> While sequence-level FAD-binding motifs can partially eliminate some distractors (D, possibly A), the positive identification of 'Antifungal biosynthesis' as the pathway requires knowledge of this protein's membership in the restricticin biosynthesis cluster, a specific and recently characterized gene cluster. This is an item-specific database/experimental fact not derivable from general biological reasoning on the sequence alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options are sufficiently distinct: ajmaline biosynthesis (plant alkaloid pathway), protein modification (generic post-translational category), antifungal biosynthesis (fungal specialized metabolite pathway), and chorismate step 7/7 (aromatic amino acid biosynthesis). Given the evidence, only C is correct. The distractors are not defensible alternatives.


### Important caveats

- The UniProt entry P0DXV5 was first published on 2025-02-05, making this a very recent annotation. The underlying paper (PubMed:39105744) was published in 2024.
- The EC number is listed as 1.-.-.- (incomplete), indicating the precise catalytic mechanism is not fully characterized.
- The paper title emphasizes 'phytotoxic activity' rather than antifungal activity, though the UniProt pathway annotation explicitly states 'Antifungal biosynthesis' with direct-assay evidence. Restricticin is known in the literature as an antifungal compound.
- The sequence is 573 aa and flagged as 'Precursor' in UniProt, suggesting post-translational processing; the pathway annotation applies to the mature protein's function within the cluster.
- The identity origin note states the accession was inferred mechanically from dataset image-path metadata, not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a Rossmann-fold-like FAD-binding motif (GAGWCGLVAA near N-terminus), consistent with FAD-dependent monooxygenase activity. This could help eliminate option D (chorismate step 7/7 = DAHP synthase, a completely different enzyme class) and arguably option A (ajmaline biosynthesis is a plant-specific alkaloid pathway involving strictosidine synthase and other enzymes, not FAD monooxygenases). However, FAD-dependent monooxygenases participate in numerous fungal secondary metabolite pathways, and the specific assignment to 'Antifungal biosynthesis' (i.e., the restricticin cluster) cannot be derived from sequence motifs alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific identity of this protein as 'Restricticin biosynthesis cluster protein A' and the classification of the restricticin pathway under 'Antifungal biosynthesis' in UniProt. This is a very recent annotation (entry first published 2025-02-05, reference paper 2024) and the restricticin biosynthesis cluster was characterized via genome mining and heterologous expression. Without knowing the protein's specific role in the restricticin gene cluster, a model cannot uniquely assign it to 'Antifungal biosynthesis' rather than another fungal secondary metabolite biosynthesis pathway.",
    "reason": "While sequence-level FAD-binding motifs can partially eliminate some distractors (D, possibly A), the positive identification of 'Antifungal biosynthesis' as the pathway requires knowledge of this protein's membership in the restricticin biosynthesis cluster, a specific and recently characterized gene cluster. This is an item-specific database/experimental fact not derivable from general biological reasoning on the sequence alone."
  },
  "case_id": "pathway_0183",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence matches UniProt entry P0DXV5 (RESA_ASPSL, FAD-dependent monooxygenase resA / Restricticin biosynthesis cluster protein A) from Aspergillus sclerotiorum. The pathway comment explicitly states 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay), referencing PubMed:39105744 (2024, J. Agric. Food Chem.). The protein is part of the restricticin biosynthesis cluster, and restricticin is an antifungal compound. The annotation is experimentally supported."
  },
  "important_caveats": [
    "The UniProt entry P0DXV5 was first published on 2025-02-05, making this a very recent annotation. The underlying paper (PubMed:39105744) was published in 2024.",
    "The EC number is listed as 1.-.-.- (incomplete), indicating the precise catalytic mechanism is not fully characterized.",
    "The paper title emphasizes 'phytotoxic activity' rather than antifungal activity, though the UniProt pathway annotation explicitly states 'Antifungal biosynthesis' with direct-assay evidence. Restricticin is known in the literature as an antifungal compound.",
    "The sequence is 573 aa and flagged as 'Precursor' in UniProt, suggesting post-translational processing; the pathway annotation applies to the mature protein's function within the cluster.",
    "The identity origin note states the accession was inferred mechanically from dataset image-path metadata, not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options are sufficiently distinct: ajmaline biosynthesis (plant alkaloid pathway), protein modification (generic post-translational category), antifungal biosynthesis (fungal specialized metabolite pathway), and chorismate step 7/7 (aromatic amino acid biosynthesis). Given the evidence, only C is correct. The distractors are not defensible alternatives."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0183",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches UniProt entry P0DXV5 (RESA_ASPSL, FAD-dependent monooxygenase resA / Restricticin biosynthesis cluster protein A) from Aspergillus sclerotiorum. The pathway comment explicitly states 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay), referencing PubMed:39105744 (2024, J. Agric. Food Chem.). The protein is part of the restricticin biosynthesis cluster, and restricticin is an antifungal compound. The annotation is experimentally supported.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains a Rossmann-fold-like FAD-binding motif (GAGWCGLVAA near N-terminus), consistent with FAD-dependent monooxygenase activity. This could help eliminate option D (chorismate step 7/7 = DAHP synthase, a completely different enzyme class) and arguably option A (ajmaline biosynthesis is a plant-specific alkaloid pathway involving strictosidine synthase and other enzymes, not FAD monooxygenases). However, FAD-dependent monooxygenases participate in numerous fungal secondary metabolite pathways, and the specific assignment to 'Antifungal biosynthesis' (i.e., the restricticin cluster) cannot be derived from sequence motifs alone.",
    "missing_item_specific_fact": "The specific identity of this protein as 'Restricticin biosynthesis cluster protein A' and the classification of the restricticin pathway under 'Antifungal biosynthesis' in UniProt. This is a very recent annotation (entry first published 2025-02-05, reference paper 2024) and the restricticin biosynthesis cluster was characterized via genome mining and heterologous expression. Without knowing the protein's specific role in the restricticin gene cluster, a model cannot uniquely assign it to 'Antifungal biosynthesis' rather than another fungal secondary metabolite biosynthesis pathway.",
    "reason": "While sequence-level FAD-binding motifs can partially eliminate some distractors (D, possibly A), the positive identification of 'Antifungal biosynthesis' as the pathway requires knowledge of this protein's membership in the restricticin biosynthesis cluster, a specific and recently characterized gene cluster. This is an item-specific database/experimental fact not derivable from general biological reasoning on the sequence alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options are sufficiently distinct: ajmaline biosynthesis (plant alkaloid pathway), protein modification (generic post-translational category), antifungal biosynthesis (fungal specialized metabolite pathway), and chorismate step 7/7 (aromatic amino acid biosynthesis). Given the evidence, only C is correct. The distractors are not defensible alternatives."
  },
  "important_caveats": [
    "The UniProt entry P0DXV5 was first published on 2025-02-05, making this a very recent annotation. The underlying paper (PubMed:39105744) was published in 2024.",
    "The EC number is listed as 1.-.-.- (incomplete), indicating the precise catalytic mechanism is not fully characterized.",
    "The paper title emphasizes 'phytotoxic activity' rather than antifungal activity, though the UniProt pathway annotation explicitly states 'Antifungal biosynthesis' with direct-assay evidence. Restricticin is known in the literature as an antifungal compound.",
    "The sequence is 573 aa and flagged as 'Precursor' in UniProt, suggesting post-translational processing; the pathway annotation applies to the mature protein's function within the cluster.",
    "The identity origin note states the accession was inferred mechanically from dataset image-path metadata, not provided to the evaluated model."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the source record, which annotates the protein's pathway as antifungal biosynthesis and cites experimental evidence (ECO:0000269) and a primary research article. This supports the key, though the article's results were not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> The protein's specific role in the antifungal biosynthetic pathway, rather than merely its enzyme family or general biochemical activity.


**Reason**

> The sequence has an N-terminal glycine-rich nucleotide-binding motif consistent with a flavoprotein, but that feature does not identify the pathway. Flavoproteins can participate in many pathways, including specialized-metabolite biosynthesis; the sequence alone does not meaningfully distinguish antifungal biosynthesis from ajmaline biosynthesis. The other choices may be less plausible from broad enzyme-family expectations, but those expectations do not establish the specific pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied evidence supports C, and no alternative is established as a second defensible answer by the sequence and choices.


### Important caveats

- The pathway evidence is a database annotation linked to a cited study; it is not a direct experimental result included in the question.
- The source identity and organism information were reviewer-only and are not treated as original inputs for answerability.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's specific role in the antifungal biosynthetic pathway, rather than merely its enzyme family or general biochemical activity.",
    "reason": "The sequence has an N-terminal glycine-rich nucleotide-binding motif consistent with a flavoprotein, but that feature does not identify the pathway. Flavoproteins can participate in many pathways, including specialized-metabolite biosynthesis; the sequence alone does not meaningfully distinguish antifungal biosynthesis from ajmaline biosynthesis. The other choices may be less plausible from broad enzyme-family expectations, but those expectations do not establish the specific pathway."
  },
  "case_id": "pathway_0183",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the source record, which annotates the protein's pathway as antifungal biosynthesis and cites experimental evidence (ECO:0000269) and a primary research article. This supports the key, though the article's results were not independently reviewed here."
  },
  "important_caveats": [
    "The pathway evidence is a database annotation linked to a cited study; it is not a direct experimental result included in the question.",
    "The source identity and organism information were reviewer-only and are not treated as original inputs for answerability."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports C, and no alternative is established as a second defensible answer by the sequence and choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0183",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the source record, which annotates the protein's pathway as antifungal biosynthesis and cites experimental evidence (ECO:0000269) and a primary research article. This supports the key, though the article's results were not independently reviewed here.",
    "evidence_ids": ["C5", "H3", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "The protein's specific role in the antifungal biosynthetic pathway, rather than merely its enzyme family or general biochemical activity.",
    "reason": "The sequence has an N-terminal glycine-rich nucleotide-binding motif consistent with a flavoprotein, but that feature does not identify the pathway. Flavoproteins can participate in many pathways, including specialized-metabolite biosynthesis; the sequence alone does not meaningfully distinguish antifungal biosynthesis from ajmaline biosynthesis. The other choices may be less plausible from broad enzyme-family expectations, but those expectations do not establish the specific pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports C, and no alternative is established as a second defensible answer by the sequence and choices."
  },
  "important_caveats": [
    "The pathway evidence is a database annotation linked to a cited study; it is not a direct experimental result included in the question.",
    "The source identity and organism information were reviewer-only and are not treated as original inputs for answerability."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV5 (FAD-dependent monooxygenase resA, restricticin biosynthesis cluster protein A) from Aspergillus sclerotiorum is explicitly annotated with PATHWAY: Antifungal biosynthesis, supported by experimental evidence (ECO:0000269|PubMed:39105744). The sequence in the question matches the canonical entry sequence exactly (573 aa, SHA256 match). The expected answer C is directly and experimentally supported.

Citations as saved: [C1](#evidence-c1), [C3](#evidence-c3), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains glycine-rich motifs (e.g., 'IGAGW' near the N-terminus, 'GGGG' stretch around residue 180) consistent with FAD-binding Rossmann-fold architecture, and the overall ~573 aa size and domain organization suggest a flavin-dependent monooxygenase. This eliminates D (chorismate synthase, step 7/7 of the shikimate pathway): chorismate synthase is a well-characterized ~240-400 aa FMN-dependent enzyme with a distinct TIM-barrel fold, incompatible with a 573-aa FAD-binding monooxygenase. It also disfavors B ('Protein modification'), a generic category for post-translational modifications (kinases, ligases, etc.), not small-molecule biosynthetic monooxygenases. Between A (ajmaline biosynthesis, a plant tryptophan-derived indole alkaloid pathway) and C (antifungal biosynthesis, a fungal secondary-metabolite pathway): FAD-dependent monooxygenases are a hallmark enzyme class in fungal secondary-metabolite biosynthetic gene clusters (polyketide, terpene, and non-ribosomal peptide tailoring), whereas ajmaline biosynthesis relies on tryptophan decarboxylase, strictosidine synthase, and P450-type dioxygenases with different architectures. The enzyme class and motif pattern thus favor a fungal secondary-metabolite context (C) over a plant alkaloid context (A).


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can use FAD-binding motif recognition to eliminate D (wrong cofactor, wrong fold, wrong size), eliminate B (wrong functional category for a biosynthetic monooxygenase), and use family-level knowledge that FAD-dependent monooxygenases are characteristic of fungal secondary-metabolite gene clusters (including antifungal compound biosynthesis) rather than plant indole-alkaloid pathways, thereby favoring C over A. The inference is probabilistic but meaningfully discriminates among the four offered choices.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> While the A-vs-C distinction relies on probabilistic family-level inference (fungal vs. plant secondary metabolism), the other two options (B and D) are clearly eliminable, and the FAD-dependent monooxygenase architecture is a well-established marker of fungal biosynthetic gene clusters, making C the most defensible choice among the four.


### Important caveats

- The FAD-binding motif recognition from sequence alone is suggestive but not definitive; the 'GxGxxG' pattern is approximate in this sequence.
- The organism (Aspergillus sclerotiorum) is not provided in the model input; the inference that this is a fungal enzyme relies on enzyme-class-to-pathway associations learned from other proteins.
- The UniProt annotation 'Antifungal biosynthesis' is a broad UniProt pathway category; the specific compound (restricticin) and its antifungal activity are established in the cited 2024 paper but are not derivable from sequence alone.
- The distinction between 'antifungal biosynthesis' and a generic 'secondary metabolite biosynthesis' label is a UniProt curation choice, not a fundamental biochemical distinction.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains glycine-rich motifs (e.g., 'IGAGW' near the N-terminus, 'GGGG' stretch around residue 180) consistent with FAD-binding Rossmann-fold architecture, and the overall ~573 aa size and domain organization suggest a flavin-dependent monooxygenase. This eliminates D (chorismate synthase, step 7/7 of the shikimate pathway): chorismate synthase is a well-characterized ~240-400 aa FMN-dependent enzyme with a distinct TIM-barrel fold, incompatible with a 573-aa FAD-binding monooxygenase. It also disfavors B ('Protein modification'), a generic category for post-translational modifications (kinases, ligases, etc.), not small-molecule biosynthetic monooxygenases. Between A (ajmaline biosynthesis, a plant tryptophan-derived indole alkaloid pathway) and C (antifungal biosynthesis, a fungal secondary-metabolite pathway): FAD-dependent monooxygenases are a hallmark enzyme class in fungal secondary-metabolite biosynthetic gene clusters (polyketide, terpene, and non-ribosomal peptide tailoring), whereas ajmaline biosynthesis relies on tryptophan decarboxylase, strictosidine synthase, and P450-type dioxygenases with different architectures. The enzyme class and motif pattern thus favor a fungal secondary-metabolite context (C) over a plant alkaloid context (A).",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can use FAD-binding motif recognition to eliminate D (wrong cofactor, wrong fold, wrong size), eliminate B (wrong functional category for a biosynthetic monooxygenase), and use family-level knowledge that FAD-dependent monooxygenases are characteristic of fungal secondary-metabolite gene clusters (including antifungal compound biosynthesis) rather than plant indole-alkaloid pathways, thereby favoring C over A. The inference is probabilistic but meaningfully discriminates among the four offered choices."
  },
  "case_id": "pathway_0183",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C3",
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV5 (FAD-dependent monooxygenase resA, restricticin biosynthesis cluster protein A) from Aspergillus sclerotiorum is explicitly annotated with PATHWAY: Antifungal biosynthesis, supported by experimental evidence (ECO:0000269|PubMed:39105744). The sequence in the question matches the canonical entry sequence exactly (573 aa, SHA256 match). The expected answer C is directly and experimentally supported."
  },
  "important_caveats": [
    "The FAD-binding motif recognition from sequence alone is suggestive but not definitive; the 'GxGxxG' pattern is approximate in this sequence.",
    "The organism (Aspergillus sclerotiorum) is not provided in the model input; the inference that this is a fungal enzyme relies on enzyme-class-to-pathway associations learned from other proteins.",
    "The UniProt annotation 'Antifungal biosynthesis' is a broad UniProt pathway category; the specific compound (restricticin) and its antifungal activity are established in the cited 2024 paper but are not derivable from sequence alone.",
    "The distinction between 'antifungal biosynthesis' and a generic 'secondary metabolite biosynthesis' label is a UniProt curation choice, not a fundamental biochemical distinction."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While the A-vs-C distinction relies on probabilistic family-level inference (fungal vs. plant secondary metabolism), the other two options (B and D) are clearly eliminable, and the FAD-dependent monooxygenase architecture is a well-established marker of fungal biosynthetic gene clusters, making C the most defensible choice among the four."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{"case_id":"pathway_0183","expected_answer_check":{"judgment":"supported","reason":"The UniProt entry P0DXV5 (FAD-dependent monooxygenase resA, restricticin biosynthesis cluster protein A) from Aspergillus sclerotiorum is explicitly annotated with PATHWAY: Antifungal biosynthesis, supported by experimental evidence (ECO:0000269|PubMed:39105744). The sequence in the question matches the canonical entry sequence exactly (573 aa, SHA256 match). The expected answer C is directly and experimentally supported.","evidence_ids":["C1","C3","C4","C5","C6","H1","H3"]},"answerability_check":{"judgment":"reasoning_supported","discriminating_biological_argument":"The sequence contains glycine-rich motifs (e.g., 'IGAGW' near the N-terminus, 'GGGG' stretch around residue 180) consistent with FAD-binding Rossmann-fold architecture, and the overall ~573 aa size and domain organization suggest a flavin-dependent monooxygenase. This eliminates D (chorismate synthase, step 7/7 of the shikimate pathway): chorismate synthase is a well-characterized ~240-400 aa FMN-dependent enzyme with a distinct TIM-barrel fold, incompatible with a 573-aa FAD-binding monooxygenase. It also disfavors B ('Protein modification'), a generic category for post-translational modifications (kinases, ligases, etc.), not small-molecule biosynthetic monooxygenases. Between A (ajmaline biosynthesis, a plant tryptophan-derived indole alkaloid pathway) and C (antifungal biosynthesis, a fungal secondary-metabolite pathway): FAD-dependent monooxygenases are a hallmark enzyme class in fungal secondary-metabolite biosynthetic gene clusters (polyketide, terpene, and non-ribosomal peptide tailoring), whereas ajmaline biosynthesis relies on tryptophan decarboxylase, strictosidine synthase, and P450-type dioxygenases with different architectures. The enzyme class and motif pattern thus favor a fungal secondary-metabolite context (C) over a plant alkaloid context (A).","missing_item_specific_fact":"","reason":"A knowledgeable model can use FAD-binding motif recognition to eliminate D (wrong cofactor, wrong fold, wrong size), eliminate B (wrong functional category for a biosynthetic monooxygenase), and use family-level knowledge that FAD-dependent monooxygenases are characteristic of fungal secondary-metabolite gene clusters (including antifungal compound biosynthesis) rather than plant indole-alkaloid pathways, thereby favoring C over A. The inference is probabilistic but meaningfully discriminates among the four offered choices."},"question_ambiguity":{"multiple_defensible_options":[],"reason":"While the A-vs-C distinction relies on probabilistic family-level inference (fungal vs. plant secondary metabolism), the other two options (B and D) are clearly eliminable, and the FAD-dependent monooxygenase architecture is a well-established marker of fungal biosynthetic gene clusters, making C the most defensible choice among the four."},"important_caveats":["The FAD-binding motif recognition from sequence alone is suggestive but not definitive; the 'GxGxxG' pattern is approximate in this sequence.","The organism (Aspergillus sclerotiorum) is not provided in the model input; the inference that this is a fungal enzyme relies on enzyme-class-to-pathway associations learned from other proteins.","The UniProt annotation 'Antifungal biosynthesis' is a broad UniProt pathway category; the specific compound (restricticin) and its antifungal activity are established in the cited 2024 paper but are not derivable from sequence alone.","The distinction between 'antifungal biosynthesis' and a generic 'secondary metabolite biosynthesis' label is a UniProt curation choice, not a fundamental biochemical distinction."]}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXV5",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "5c9bec79fdb8d5271f890a14ee63b46b7cfaeed192dc232d6d13c5da622ee245",
  "benchmark_sequence_length": 573,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 5,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "e707f20abd7826b390bb5fc8cb46d8df7f258be31be61e0129f1d19c24be05d4",
  "current_source_sequence_sha256": "5c9bec79fdb8d5271f890a14ee63b46b7cfaeed192dc232d6d13c5da622ee245",
  "current_source_sequence_length": 573,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 3,
  "selected_historical_version": {
    "accession": "P0DXV5",
    "database": "Swiss-Prot",
    "entryVersion": 3,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RESA_ASPSL",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "8f3c70f33ba4a6cc4d094784bec8580161b3aa6521967c7a1063dc12558b2f14",
  "selected_historical_source_sequence_sha256": "5c9bec79fdb8d5271f890a14ee63b46b7cfaeed192dc232d6d13c5da622ee245",
  "selected_historical_source_sequence_length": 573,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 3,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV5.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV5.json",
  "source_sha256": "e707f20abd7826b390bb5fc8cb46d8df7f258be31be61e0129f1d19c24be05d4",
  "retrieved_utc": "2026-11-02T04:29:47.174193+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXV5\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV5.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV5.json",
  "source_sha256": "e707f20abd7826b390bb5fc8cb46d8df7f258be31be61e0129f1d19c24be05d4",
  "retrieved_utc": "2026-11-02T04:29:47.174193+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":5,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV5.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV5.json",
  "source_sha256": "e707f20abd7826b390bb5fc8cb46d8df7f258be31be61e0129f1d19c24be05d4",
  "retrieved_utc": "2026-11-02T04:29:47.174193+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus sclerotiorum\",\"taxonId\":138282}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV5.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV5.json",
  "source_sha256": "e707f20abd7826b390bb5fc8cb46d8df7f258be31be61e0129f1d19c24be05d4",
  "retrieved_utc": "2026-11-02T04:29:47.174193+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein A\"}}],\"flag\":\"Precursor\",\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"1.-.-.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"FAD-dependent monooxygenase resA\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV5.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV5.json",
  "source_sha256": "e707f20abd7826b390bb5fc8cb46d8df7f258be31be61e0129f1d19c24be05d4",
  "retrieved_utc": "2026-11-02T04:29:47.174193+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV5.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV5.json",
  "source_sha256": "e707f20abd7826b390bb5fc8cb46d8df7f258be31be61e0129f1d19c24be05d4",
  "retrieved_utc": "2026-11-02T04:29:47.174193+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Lu Y.\",\"Li Y.\",\"Dou M.\",\"Liu D.\",\"Lin W.\",\"Fan A.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39105744\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.jafc.4c04244\"}],\"citationType\":\"journal article\",\"firstPage\":\"18520\",\"id\":\"39105744\",\"journal\":\"J. Agric. Food Chem.\",\"lastPage\":\"18527\",\"publicationDate\":\"2024\",\"title\":\"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.\",\"volume\":\"72\"},\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV5?format=txt&versions=3)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV5?format=txt&versions=3",
  "source_sha256": "8f3c70f33ba4a6cc4d094784bec8580161b3aa6521967c7a1063dc12558b2f14",
  "retrieved_utc": "2026-11-02T04:29:49.115408+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   RESA_ASPSL              Reviewed;         573 AA.\nAC   P0DXV5;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 3.\nDE   RecName: Full=FAD-dependent monooxygenase resA {ECO:0000303|PubMed:39105744};\nDE            EC=1.-.-.- {ECO:0000305|PubMed:39105744};\nDE   AltName: Full=Restricticin biosynthesis cluster protein A {ECO:0000303|PubMed:39105744};\nDE   Flags: Precursor;\nGN   Name=resA {ECO:0000303|PubMed:39105744};\nOS   Aspergillus sclerotiorum.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=138282;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 3,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV5?format=txt&versions=3)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV5?format=txt&versions=3",
  "source_sha256": "8f3c70f33ba4a6cc4d094784bec8580161b3aa6521967c7a1063dc12558b2f14",
  "retrieved_utc": "2026-11-02T04:29:49.115408+00:00",
  "source_locator": "lines 16-22",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;\nRA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;\nRT   \"Discovery of a hybrid molecule with phytotoxic activity by genome mining,\nRT   heterologous expression, and OSMAC strategy.\";\nRL   J. Agric. Food Chem. 72:18520-18527(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 3,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV5?format=txt&versions=3)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV5?format=txt&versions=3",
  "source_sha256": "8f3c70f33ba4a6cc4d094784bec8580161b3aa6521967c7a1063dc12558b2f14",
  "retrieved_utc": "2026-11-02T04:29:49.115408+00:00",
  "source_locator": "lines 41-41",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:39105744}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 3,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 183. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
